Crescent Biopharma, Inc. (CBIO) vs Electra Therapeutics Inc. (ETRA)

Crescent Biopharma, Inc. CBIO 13.48 +4.17%
Electra Therapeutics Inc. ETRA 7.80 +6.12%

Crescent Biopharma, Inc. and Electra Therapeutics Inc. are both Biotechnology companies. Crescent Biopharma, Inc. and Electra Therapeutics Inc. are of similar size ($480.6M and $461.3M).

Metric	CBIO	ETRA	Biotechnology median
P/E	n/m	—	10.60
P/S	337.85	—	9.40
P/B	2.58	—	2.13
Price to free cash flow	n/m	—	25.18
EV/EBITDA	n/m	—	0.66
EV/Sales	227.76	—	9.02
Earnings yield	(49.85%)	—	(32.88%)
Free cash flow yield	(17.46%)	—	(23.13%)

Metric	CBIO	ETRA	Biotechnology median
Gross margin	19.72%	—	68.51%
Operating margin	0.00%	—	0.00%
Net margin	0.00%	—	0.00%
Free cash flow margin	0.00%	—	0.00%
Return on equity	(101.95%)	—	(51.96%)
Return on assets	(88.26%)	—	(46.06%)
Return on invested capital	0.00%	—	0.00%

Metric	CBIO	ETRA	Biotechnology median
Revenue growth (TTM)	(45.09%)	—	6.76%
EPS growth (last fiscal year)	78.20%	—	29.88%
Revenue growth, 5-year CAGR	257.77%	—	9.75%
Net income growth, 5-year CAGR	0.00%	—	0.00%

Metric	CBIO	ETRA	Biotechnology median
Debt to equity	0.00	—	0.00
Current ratio	9.66	—	4.97
Net debt to EBITDA	1.40	—	1.01

Metric	CBIO	ETRA	Biotechnology median
Dividend yield	—	—	0.41%
Payout ratio	—	—	—

Metric	CBIO	ETRA	Biotechnology median
Market cap	480.64m	461.33m	161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack